- Home
- TMQ vs FENC Comparison
TMQ vs FENC Comparison
Compare TMQ & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMQ
- FENC
- Stock Information
- Founded
- TMQ 2004
- FENC 1996
- Country
- TMQ Canada
- FENC United States
- Employees
- TMQ N/A
- FENC N/A
- Industry
- TMQ Precious Metals
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TMQ Basic Materials
- FENC Health Care
- Exchange
- TMQ Nasdaq
- FENC Nasdaq
- Market Cap
- TMQ 211.9M
- FENC 222.9M
- IPO Year
- TMQ N/A
- FENC 2001
- Fundamental
- Price
- TMQ $1.37
- FENC $8.36
- Analyst Decision
- TMQ
- FENC Strong Buy
- Analyst Count
- TMQ 0
- FENC 2
- Target Price
- TMQ N/A
- FENC $13.00
- AVG Volume (30 Days)
- TMQ 340.6K
- FENC 77.6K
- Earning Date
- TMQ 07-09-2025
- FENC 08-12-2025
- Dividend Yield
- TMQ N/A
- FENC N/A
- EPS Growth
- TMQ N/A
- FENC N/A
- EPS
- TMQ N/A
- FENC N/A
- Revenue
- TMQ N/A
- FENC $30,912,000.00
- Revenue This Year
- TMQ N/A
- FENC $0.85
- Revenue Next Year
- TMQ N/A
- FENC $55.16
- P/E Ratio
- TMQ N/A
- FENC N/A
- Revenue Growth
- TMQ N/A
- FENC N/A
- 52 Week Low
- TMQ $0.47
- FENC $3.96
- 52 Week High
- TMQ $2.09
- FENC $8.72
- Technical
- Relative Strength Index (RSI)
- TMQ 50.89
- FENC 59.42
- Support Level
- TMQ $1.35
- FENC $7.94
- Resistance Level
- TMQ $1.53
- FENC $8.51
- Average True Range (ATR)
- TMQ 0.07
- FENC 0.44
- MACD
- TMQ 0.01
- FENC -0.03
- Stochastic Oscillator
- TMQ 48.39
- FENC 71.86
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.